Main Management ETF Advisors »

Bridgebio Pharma shares owned by Main Management ETF Advisors

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Main Management ETF Advisors from 13F filings

Historical chart of Main Management ETF Advisors investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Main Management ETF Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Main Management ETF Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.6M 30k 51.94
2025-06-30 $981k 23k 43.17
2025-03-31 $773k 22k 34.58

More positions owned by Main Management ETF Advisors

Technology SPDR (XLK)
Select Sector Spdr Tr Communic etfeqty (XLC)
Health Care SPDR (XLV)
Financial Select Sector SPDR (XLF)
Consumer Discretionary SPDR (XLY)
Vaneck Vectors Semiconductor Etf semiconductor (SMH)
iShares S&P NA Tec.-SW. Idx. Fund (IGV)
iShares Dow Jones US Home Const. (ITB)
Ishares Tr core msci intl (IDEV)
Ishares Inc core msci emkt (IEMG)
State Street Institutional Treasury MM Fund (TRIXX)
Spdr Index Shs Fds stoxx eur 50 etf (SPEU)
Kraneshares Tr csi chi internet (KWEB)
SPDR S&P Emerging Markets (SPEM)
Network Associates Inc cl a (NET)

View all positions for Main Management ETF Advisors

Top funds holding Bridgebio Pharma

Vanguard Group
Viking Global Investors
BlackRock
Kohlberg Kravis Roberts & Co
Henderson Group
Farallon Capital Management
UBS Group
Aisling Capital Management
State Street Corporation
Jane Street
Susquehanna International
Invesco
Geode Capital Management
Frazier Life Sciences Management
Two Sigma Investments

View all funds holding Bridgebio Pharma